Trending Now
Agenus (NASDAQ: AGEN) Presents Clinical Data Evaluating AGEN1181 As A Monotherapy...
Agenus (NASDAQ: AGEN) presented new clinical data for AGEN1181 as a monotherapy and in combination with balstiilimab at the 36th Annual Society of Immunotherapy...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Inovio Pharmaceuticals Inc (NASDAQ:INO) Reports Favorable Data Of INO-4800 In NHP...
Inovio Pharmaceuticals Inc (NASDAQ:INO) reported encouraging results in treating one of the difficult and most devastating cancers, GBM (glioblastoma multiforme). The company also achieved...
MAKE IT MODERN
LATEST REVIEWS
Adaptive Technologies Corporation (NASDAQ: ADPT) Presents Data on Crohn’s Disease-Related T-Cell...
Adaptive Technologies Corporation (NASDAQ: ADPT) presented data on T-cell receptor sequences related to Crohn’s disease (CD) during the 17th Congress of European Crohn’s and...
MAKE IT MODERN
PERFORMANCE TRAINING
Chiasma Inc.’s (NASDAQ:CHMA) Positive Results Form MPOWERED Study To Support MAA In EU For...
Chiasma Inc. (NASDAQ:CHMA) has announced encouraging top-line results from the global Phase 3 MPOWERED™ non-inferiority study. The clinical study evaluated MYCAPSSA® (oral...
The Sustainability Trade Heads for Wall Street Dominance (MASN, FSLR, CSIQ, SPWR, TSLA, BE)
Wall Street is increasingly beholden to the values and ideals of “the new kids on the investing block” as the Millennials and...
Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) Announces Q3 2021 Financial Results And Updates On Expansion...
Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) has announced financial results for the quarter ending September 30, 2021, and offered a business update.
Corvus ended Q3 2021...
Cerus Corporation (NASDAQ: CERS) Announced New Tech Add-On Payment by CMS for INTERCEPT Fibrinogen...
Cerus Corporation (NASDAQ: CERS) recently announced that the CMS (Centers of Medicare and Medical Services) gave the company new tech add-on payments for INTERCEPT Fibrinogen...
CohBar Inc. (NASDAQ:CWBR) Has Dosed the First Subjects with CB4211 in its Phase 1b...
Under the headship of internationally recognized leaders in their fields, CohBar Inc. (NASDAQ:CWBR) has continued to stay ahead of the industry to develop mitochondria-based...























































